Capillary Technologies India Limited
Information Technology›Information Technology›IT - Software›Software Products
Key metrics
Price as of 2026-07-17
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2025 | Mar 2026 |
|---|---|---|
| Sales | 184 Cr | 191 Cr |
| Operating expenses (approx.) | 155 Cr | 128 Cr |
| EBITDA | 29 Cr | 63 Cr |
| OPM % | 15.6% | 33.0% |
| Other income | 4 Cr | 7 Cr |
| Interest | 1 Cr | 1 Cr |
| Depreciation | 19 Cr | 20 Cr |
| Profit before tax | 8 Cr | 42 Cr |
| Tax % | 1.6% | -2.1% |
| Net profit | 8 Cr | 43 Cr |
| EPS (₹) | ₹1.05 | ₹5.47 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2026 | TTM |
|---|---|---|
| Sales | 735 Cr | Sign in for TTM |
| Operating expenses (approx.) | 603 Cr | Sign in for TTM |
| EBITDA | 132 Cr | Sign in for TTM |
| OPM % | 17.9% | Sign in for TTM |
| Other income | 14 Cr | Sign in for TTM |
| Interest | 5 Cr | Sign in for TTM |
| Depreciation | 75 Cr | Sign in for TTM |
| Profit before tax | 51 Cr | Sign in for TTM |
| Tax % | -2.5% | Sign in for TTM |
| Net profit | 52 Cr | Sign in for TTM |
| EPS (₹) | ₹6.94 | Sign in for TTM |
| Dividend payout % | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2026 |
|---|---|
| Equity capital | 16 Cr |
| Reserves | 1,008 Cr |
| Borrowings | 45 Cr |
| Other liabilities | 232 Cr |
| Total liabilities | 1,300 Cr |
| Fixed assets (net) | 4 Cr |
| CWIP | 0.0000 Cr |
| Investments | 136 Cr |
| Other assets | 721 Cr |
| Total assets | 1,300 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2026 |
|---|---|
| Cash from operating activity | 150 Cr |
| Cash from investing | -614 Cr |
| Cash from financing | 271 Cr |
| Net cash flow | -169 Cr |
| Free cash flow (OCF − Capex) | 111 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2026 |
|---|---|
| ROCE % | 5.3% |
| ROE % | 5.1% |
| Debtor days | — |
| Inventory days | 0 |
| Days payable | — |
| Cash conversion cycle | 0 |
| Debt / equity | 0.04 |
| Current ratio | 2.80 |
| Net debt / EBITDA | 0.07 |
Compare with peers
Loading peers…